WO2026090627 - STABLE PITOLISANT LIQUID FORMULATIONS AND METHOD OF ITS USE
National phase entry is expected:
Publication Number
WO/2026/090627
Publication Date
30.04.2026
International Application No.
PCT/US2025/052742
International Filing Date
27.10.2025
Title **
[English]
STABLE PITOLISANT LIQUID FORMULATIONS AND METHOD OF ITS USE
[French]
FORMULATIONS LIQUIDES STABLES DE PITOLISANT ET LEUR PROCÉDÉ D'UTILISATION
Applicants **
PATEL, Sandipkumar
Inventors
PATEL, Sandipkumar
Priority Data
63/711,702
25.10.2024
US
63/751,532
30.01.2025
US
63/787,829
12.04.2025
US
63/891,890
01.10.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3629 | |
| EPO | Filing, Examination, Granting | 17737 | |
| Japan | Filing, Examination, Granting | 2742 | |
| South Korea | Filing, Examination, Granting | 3499 | |
| USA | Filing, Examination, Granting | 8160 |
Total:
35,767
Contact Us
Abstract[English]
Liquid pharmaceutical formulation of pitolisant or pharmaceutically acceptable salt thereof and its method of use are provided. The liquid formulation of pitolisant comprises Pitolisant or its pharmaceutically acceptable salt, a vehicle or solvent, and one or more optional pharmaceutically acceptable excipients. The method of preparing the liquid pitolisant formulation and the use of such formulation for the treatment of diseases treatable by pitolisant is described.[French]
L'invention concerne la formulation pharmaceutique liquide de pitolisant ou d'un sel pharmaceutiquement acceptable de celui-ci et son procédé d'utilisation. La formulation liquide de pitolisant comprend du pitolisant ou son sel pharmaceutiquement acceptable, un véhicule ou un solvant, et un ou plusieurs excipients pharmaceutiquement acceptables facultatifs. L'invention concerne le procédé de préparation de la formulation liquide de pitolisant et l'utilisation d'une telle formulation pour le traitement de maladies pouvant être traitées par le pitolisant.